Solutions for Oncologists
Commercially available tests provide information that can help advanced cancer patients obtain the right treatment.
All our solutions for patients with cancer are supported by Anpac Bio’s proprietary CDA technology, which revolutionizes early cancer screening and detection–allowing medical professionals more treatment options and patients more opportunities to beat the disease and enjoy healthy lives.
CDA technology analyzes in vitro “Blood Biopsies,” applying Anpac Bio’s proprietary, multi-level multi-parameter screening algorithms to identify over 26+ cancers with greater sensitivity and specificity, fewer “false positives,” at a cost that is substantially less than traditional screening methods, such as imaging and tissue biopsy.
Read about our CDA technology at the Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.
Read the full article